INSERM U827, Laboratoire de Génétique de Maladies Rares, Montpellier, France.
Eur J Hum Genet. 2012 Feb;20(2):180-4. doi: 10.1038/ejhg.2011.161. Epub 2011 Aug 17.
In monogenic diseases, the presence of several sequence variations in the same allele may complicate our understanding of genotype-phenotype relationships. We described new alterations identified in a cystic fibrosis (CF) patient harboring a 48C>G promoter sequence variation associated in cis of a 3532AC>GTA mutation and in trans with the F508del mutation. Functional analyses including in vitro experiments confirmed the deleterious effect of the 3532GTA frameshift mutation through the creation of a premature termination codon. The analyses also revealed that the 48G promoter variant has a negative effect on both transcription and mRNA level, thus demonstrating the importance of analyzing all mutations or sequence variations with potential impact on CF transmembrane conductance regulator processing, even when the two known disease-causing mutations have already been detected. Our results emphasize the need to perform, wherever possible, functional studies that may greatly assist the interpretation of the disease-causing potential of rare mutation-associated sequence variations.
在单基因疾病中,同一等位基因中存在多个序列变异可能会使我们对基因型-表型关系的理解变得复杂。我们描述了一位囊性纤维化 (CF) 患者中发现的新改变,该患者携带一个 48C>G 启动子序列变异,与 3532AC>GTA 突变顺式相关,与 F508del 突变反式相关。包括体外实验在内的功能分析证实了 3532GTA 移码突变通过创建一个过早终止密码子产生了有害影响。分析还表明,48G 启动子变体对转录和 mRNA 水平都有负面影响,因此证明了分析所有可能影响 CF 跨膜电导调节剂加工的突变或序列变异的重要性,即使已经检测到两个已知的致病突变。我们的研究结果强调了在可能的情况下进行功能研究的必要性,这可能极大地有助于解释与罕见突变相关的序列变异的致病潜力。